Hemimegalencephaly is a rare brain malformation in which one half of the brain grows abnormally large during fetal development, producing a hemisphere that is not just bigger but structurally disorganized at the cellular level. It causes severe, often drug-resistant epilepsy that typically begins in the first weeks or months of life, along with developmental delays and weakness on the opposite side of the body. The condition has gone from a mysterious anatomical curiosity to one whose genetic roots are increasingly understood, and that shift has opened new avenues for both diagnosis and treatment.
What Goes Wrong During Brain Development
The affected hemisphere in hemimegalencephaly is not simply a scaled-up version of normal brain tissue. Under a microscope, the tissue shows profoundly disorganized architecture in both gray and white matter, including abnormally large neurons and distinctive “balloon cells” that do not belong in healthy cortex.1PubMed. Hemimegalencephaly: part 2. Neuropathology suggests a disorder of cellular lineage The cortex is thicker than it should be, the folds (sulci) are abnormally shallow, and the normal layered organization of nerve cells is scrambled. This is not a tumor; it is a developmental misstep that distorts the blueprint of the hemisphere from very early in gestation.
The enlargement can be confined to the cerebral hemisphere on one side, but in some patients it extends further. A study of 30 patients found that almost half had enlargement of the cerebellum on the same side, and a smaller number had enlargement of the brainstem as well.2PubMed Central. Hemimegalencephaly: a study of abnormalities occurring outside the involved hemisphere That finding matters because it means the condition is not always limited to one cerebral hemisphere, even though the name implies it.
The Genetic Discovery That Changed the Field
For decades, clinicians had no molecular explanation for why one half of the brain would overgrow while the other developed normally. That changed around 2012, when several research groups independently identified the culprit: mutations in a signaling cascade that tells cells when to grow and divide. By comparing DNA from surgically removed brain tissue with blood samples from the same patients, researchers found that about 30% of individuals with hemimegalencephaly carried mutations in genes called PIK3CA, AKT3, or MTOR, and that the mutations existed only in brain tissue, not throughout the body.3Nature Genetics. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly One specific PIK3CA mutation kept turning up in unrelated patients, hinting at a mutational hotspot.
The mutations are “somatic mosaics,” meaning they arise spontaneously in one cell at some point after conception and then spread to all daughter cells of that lineage, but not to the entire body. This explains why only one hemisphere is affected: the mutation arose in a progenitor cell destined to build that hemisphere, and every neuron descended from it inherited the growth-promoting error. The proportion of cells carrying the mutation varied from roughly 8% to 40% of brain cells in different regions, which may partly explain why some cases are more severe than others.4Nature Genetics. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
Subsequent studies expanded the list of genes involved and confirmed the same core pathway. Targeted and exome sequencing of brain and non-brain samples from 53 patients with hemimegalencephaly or the related condition focal cortical dysplasia identified pathogenic mutations in multiple genes within the same signaling network.5PubMed Central. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia The consistent thread is that all the implicated genes feed into a single growth-regulation pathway. When that pathway is switched on too aggressively, cells grow too large and too fast, and the hemisphere balloons.6PubMed. Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders
How It Presents in Infants and Children
The hallmark of hemimegalencephaly is epilepsy, and it tends to arrive early and aggressively. A nationwide survey in Japan found that every patient had epileptic seizures, with onset occurring within the first month of life in a large proportion of cases and within six months in most of the rest.7PubMed. Clinical aspects of hemimegalencephaly by means of a nationwide survey The seizures are frequently resistant to standard anti-seizure medications from the start. In the same survey, the majority of patients had intellectual disability and weakness on the side of the body opposite the enlarged hemisphere, and a notable fraction were eventually bedridden.8PubMed. Clinical aspects of hemimegalencephaly by means of a nationwide survey
The EEG patterns seen in hemimegalencephaly are distinctive, though not unique. Several patterns have been documented, including a “suppression-burst” pattern in which bursts of electrical activity alternate with periods of near-silence. Other patterns include continuous high-amplitude slow waves with spikes and repetitive triphasic complexes.9PubMed. Interictal epileptogenic fast oscillations on neonatal and infantile EEGs in hemimegalencephaly The suppression-burst pattern is often considered characteristic of the condition, though how long it persists varies between patients and does not reliably predict long-term outcomes on its own.10PubMed. Electroclinical characteristics of hemimegalencephaly
Conditions That Travel With It
Hemimegalencephaly can occur in isolation, but it also shows up as part of broader overgrowth syndromes. Proteus syndrome, which involves asymmetric overgrowth of skin, bone, and other tissues, has been reported alongside hemimegalencephaly and severe early-onset epilepsy in multiple case studies.11PubMed. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: report of two cases Other overgrowth conditions linked to hemimegalencephaly include epidermal nevus syndrome, Klippel-Trenaunay-Weber syndrome, and tuberous sclerosis complex. The common thread is that many of these syndromes also involve dysregulated cell growth signaling, sometimes in the same molecular pathway.
When hemimegalencephaly appears alongside one of these syndromes, managing the neurological complications early can reduce disability and other downstream consequences.12PubMed Central. Proteus Syndrome with Neurological Manifestations: A Rare Presentation Because the overgrowth syndromes themselves carry their own medical complications, children with syndromic hemimegalencephaly tend to need a particularly broad team of specialists.
How Hemimegalencephaly Is Diagnosed
The most common route to diagnosis is brain imaging prompted by seizures in early infancy. On MRI, the affected hemisphere is visibly larger, the ventricle on that side is often widened, the brain’s midline structures are pushed toward the smaller hemisphere, and the cortex appears abnormally thick with shallow sulci.13PubMed Central. Prenatal diagnosis of hemimegalencephaly via transabdominal and transvaginal ultrasonography: a case description These features are usually striking enough that the diagnosis is not subtle on postnatal imaging.
Prenatal detection is possible but trickier. Asymmetric enlargement of the ventricles is often the first sign picked up on routine second- or third-trimester ultrasound, but that finding is nonspecific and can point toward many conditions. High-resolution fetal neurosonography and fetal MRI are needed to confirm the diagnosis before birth, revealing the cortical migration abnormalities that distinguish hemimegalencephaly from other causes of asymmetric ventricles.14PubMed. Neuroimaging Findings in Fetal Hemimegalencephaly: Case Study and Review Complicating matters further, the imaging findings can evolve during pregnancy, making early-gestation scans harder to interpret than later ones.15PubMed Central. Prenatal Diagnosis of Hemimegalencephaly Using Radiological Methods: A Case Report
When the condition is identified prenatally, it allows families and medical teams to plan delivery at a center equipped for neonatal neurology, to arrange early EEG monitoring, and to begin conversations about surgical options before the seizures start. That advance preparation can meaningfully shape the timing of intervention.16PubMed. Prenatal diagnosis of hemimegalencephaly
Distinguishing It From Other Conditions
A few other conditions can produce a hemisphere that looks abnormal on imaging and causes drug-resistant epilepsy, so the differential diagnosis matters. Rasmussen encephalitis, for instance, is an inflammatory brain disease that affects one hemisphere and also leads to progressive weakness and seizures. However, Rasmussen encephalitis develops after birth in a previously normal brain, whereas hemimegalencephaly is present from the start of brain development. The two can usually be distinguished by their radiological and histological appearance, though occasional cases have overlapping features.17PubMed. Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population Getting this distinction right is important because the surgical approach and prognosis differ.
Why Seizures Are So Hard to Control With Medication
The seizures in hemimegalencephaly tend to be relentlessly drug-resistant. The reason is structural: the entire hemisphere is a seizure-generating zone, with abnormal neurons firing chaotically across a vast area of malformed cortex. Standard anti-seizure medications work by modulating normal neuronal firing patterns, but they struggle against an entire hemisphere of profoundly disorganized tissue. In one case report, a child’s seizures persisted through nine different anti-seizure medications and a ketogenic diet before any alternative approach was tried.18American Epilepsy Society. mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report
Because the underlying genetic defect involves overactivation of the mTOR growth-signaling pathway, drugs that directly inhibit that pathway have attracted interest as a potential bridge therapy. In the case just described, the mTOR inhibitor rapamycin (sirolimus) reduced seizure frequency by more than half within one week.19American Epilepsy Society. mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report That is a single case, not a clinical trial, and the approach remains experimental for hemimegalencephaly specifically. Still, mTOR inhibitors are considered promising candidates for further study in epilepsy caused by cortical malformations that share this pathway.20PubMed Central. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development
Surgery as the Primary Treatment
For most children with hemimegalencephaly and drug-resistant seizures, the definitive treatment is hemispherectomy or hemispherotomy, which means surgically disconnecting or removing the affected hemisphere. The idea of removing half a child’s brain sounds extreme, but the malformed hemisphere is not contributing useful function and is actively harming the rest of the brain through constant seizure activity. Hemispherectomy is widely regarded as the most effective treatment for seizure control in this population, and the literature suggests it also provides better developmental outcomes when performed early.21SpringerLink / Childs Nervous System. Hemimegalencephaly: clinical implications and surgical treatment
Seizure freedom rates after surgery vary across studies. One large series from UCLA found that about half of patients were seizure-free at a median follow-up of roughly four and a half years.22Epilepsia. Hemispheric epilepsy surgery for hemimegalencephaly: The UCLA experience A broader multicenter analysis of hemispherotomy outcomes across multiple etiologies found that about three-quarters of all children achieved seizure freedom, but hemimegalencephaly was specifically associated with a higher odds of seizure recurrence compared to other causes.23PubMed. Not surgical technique, but etiology, contralateral MRI, prior surgery, and side of surgery determine seizure outcome after pediatric hemispherotomy In other words, hemimegalencephaly is among the harder diagnoses to cure surgically even within the already-difficult population of children needing hemisphere surgery.
Several factors predict better seizure outcomes. Earlier age at seizure onset (which paradoxically may reflect a less aggressive form of epilepsy), absence of continuous partial seizures before surgery, and a normal-appearing opposite hemisphere on MRI all independently predicted longer seizure-free periods in the UCLA cohort.24Epilepsia. Hemispheric epilepsy surgery for hemimegalencephaly: The UCLA experience Abnormalities on the contralateral MRI and prior failed resective surgery were also identified as risk factors for recurrence in the multicenter study.25PubMed. Not surgical technique, but etiology, contralateral MRI, prior surgery, and side of surgery determine seizure outcome after pediatric hemispherotomy
What Happens to Development After Surgery
The developmental picture after hemispherectomy is more complex than the seizure picture. Among children who became seizure-free, the developmental benefits were real but variable. One study of infants who underwent hemispherotomy for hemimegalencephaly found that seizure-free patients had significantly higher developmental scores than those who continued to have seizures, and that shorter duration of seizures before surgery correlated with better developmental outcomes.26PubMed. Long-term developmental outcome after early hemispherotomy for hemimegalencephaly in infants with epileptic encephalopathy Yet even with early surgery, cognitive outcomes were heterogeneous; some patients operated on early still had poor development, suggesting factors beyond timing also play a role.27PubMed Central. Hemispherotomy in Infants with Hemimegalencephaly: Long-Term Seizure and Developmental Outcome in Early Treated Patients
A study of cognitive and language outcomes after cerebral hemispherectomy for hemimegalencephaly found that at follow-up, about 43% of patients had average or only mildly impaired cognition, roughly a quarter could speak at an age-appropriate level, and about a fifth had satisfactory reading skills. Children who had their right hemisphere removed (leaving the left, which is typically dominant for language) and those whose epilepsy began later were more likely to have better cognitive and language outcomes.28PubMed Central. Functional cognitive and language outcomes after cerebral hemispherectomy for hemimegalencephaly The fact that a meaningful minority of children develop functional language even after losing the hemisphere that housed their language areas speaks to the extraordinary plasticity of the young brain.
The Caregiver Perspective
Families navigating hemimegalencephaly face an unusual combination of stresses: a severe diagnosis often delivered in infancy, the prospect of major brain surgery, uncertain developmental outcomes, and long-term caregiving demands. A retrospective study assessing quality of life and caregiver burden after hemispherotomy found that overall quality of life improved for children at two years post-surgery, with gains especially in the physical and cognitive-educational domains, though psychological well-being actually declined and social/family functioning stayed roughly the same. About three-quarters of the patients in that study achieved the best seizure outcome category. Despite the children’s improvements, most caregivers rated their own burden as mild to moderate, and that burden did not improve after surgery.29SpringerLink / Childs Nerv Syst. Impact of hemispherotomy on quality of life and burden of children and adolescents: a retrospective observational study In other words, even when the surgery “works” from a seizure standpoint, the reality of raising a child with significant neurological differences continues to weigh on families.
New Research Directions
The identification of the mTOR-pathway mutations has created a direct link between the genetics of hemimegalencephaly and laboratory tools that already exist for studying cell growth. Researchers are now building mouse models carrying the same mutations found in patients and growing human cerebral organoids (essentially miniature brain-like structures grown from human stem cells) to study how the mutations lead to overgrowth and how epileptic networks form in malformed tissue.30PubMed Central. Mechanistic Target of Rapamycin and Megalencephaly: Novel Research Strategies for Therapeutic Discovery These model systems offer a way to test drugs before they reach clinical trials, and they may help answer questions that patient studies cannot easily address, such as why some mutations produce hemimegalencephaly while closely related mutations produce milder forms of cortical dysplasia.
The broader hope is that understanding the pathway well enough could eventually allow targeted therapies that go beyond surgery. If mTOR inhibitors or next-generation drugs could be given early enough, they might reduce seizure burden or slow overgrowth even before surgery is feasible. That remains speculative, but the genetic insights have moved hemimegalencephaly from a condition that was purely described at the bedside to one with a clear molecular target that drug developers already know how to hit.